Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-02-25 @ 6:56 PM
Study NCT ID:
NCT04032158
Status:
TERMINATED
Last Update Posted:
2021-08-05
First Post:
2019-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-23
First Submit QC Date:
None
Study First Post Date:
2019-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-31
Results First Submit QC Date:
None
Results First Post Date:
2021-08-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-13
Last Update Post Date:
2021-08-05
Last Update Post Date Type:
ACTUAL